
In a ruling last October, the U.S. Court of Appeals for the Federal Circuit had directed a lower court to dismiss a lawsuit Stanford had brought accusing the pharmaceutical company Roche of infringing its patents on a technology that measures the concentration of HIV in blood plasma. Stanford lost the case, essentially, because its policy on who owns inventions created using university resources required researchers, at some future date, to "agree to assign" ownership rights to the university. Meanwhile, the comparable policy at Cetus, the Roche-owned company with which the Stanford researcher, Mark Holodniy, did outside work, required the inventor to assign his rights to the company immediately. So while a federal district court backed Stanford's lawsuit challenging Roche's patents on the HIV technology, the Federal Circuit court ruled that Stanford had relinquished its rights to the patents because Holodniy had assigned ownership of his rights to Cetus/Roche.
The Inside Higher Ed full report is at http://www.insidehighered.com/news/2010/11/02/supreme_stanford
The brief supported by the Regents is at http://www.acenet.edu/AM/Template.cfm?Section=Site_Navigation&TEMPLATE=/CM/ContentDisplay.cfm&CONTENTID=36332
Maybe the lower court wasn't sufficiently sympathetic:
No comments:
Post a Comment